Brigham Researchers Develop Smartphone-Based Ovulation Test

Investigators from Brigham and Women's Hospital are developing an automated, low-cost tool to predict a woman's ovulation and aid in family planning. Capitalizing on advancements in several areas, including microfluidics, artificial intelligence (AI) and the ubiquity of smartphones, the team has built an ovulation testing tool that can automatically detect fern patterns - a marker of ovulation - in a saliva sample. The team evaluated the performance of the device using artificial saliva in the lab and validated results in human saliva samples from six subjects, observing greater than 99 percent accuracy in effectively predicting ovulation. The team's results are published in Lab on a Chip.

"Before we started this project, we weren't aware that such a need existed. When we published last year on a technology for analyzing sperm to detect male infertility, we were approached by those who had read about our work and were wondering if we could develop a smart-phone based system to provide ovulation testing at home," said corresponding author Hadi Shafiee, PhD, principal investigator at the BWH Division of Engineering in Medicine and Renal Division of Medicine. "Our study indicates that an accurate, automated and low-cost test is indeed possible."

Current methods for monitoring woman's fertility are often costly or subjective. These methods include ovulation detection through luteinizing hormone (LH) level determination (a clinical blood test or at-home urine "dip stick" test), rectal or basal body temperature analysis, cervical mucus characterization and salivary ferning analysis. Salivary ferning refers to the unique appearance of dried saliva from a woman who is ovulating - when collected on a glass slide, saliva takes on a crystallized structure that resembles fern leaves. While relatively inexpensive and simple, salivary fern analysis is highly subjective; when performed by the lay consumer, this approach is prone to misinterpretation.

To overcome this challenge, Shafiee and colleagues developed an automated process for detecting ferning in a saliva sample. The developed AI algorithm was pre-trained with 1.4 million ImageNet images and retrained with more than 1500 salivary ferning images to be able to classify saliva images into two categories: Ovulating and non-ovulating samples.

The team then evaluated the system's ability to differentiate ovulating and non-ovulating human saliva samples from six subjects. The women collected and tested their saliva samples using the cellphone system during both ovulating and non-ovulating phases of their menstrual cycle (results were confirmed using a urine test). To perform the test, saliva was collected on a microfluidic device, smeared, and left to air dry. The microfluidic device with the air-dried sample was then inserted into a 3-D printed optical attachment affixed to a smartphone. The software then analyzed the fern patterns, correctly identifying ovulation in 99 percent of samples and non-ovulation in 100 percent of the samples.

"One of the biggest advantages to this method is cost - whereas the cost of non-reusable urine stick tests can add up to $210 to $240 over the course of six months, our device represents the possibility of a one-time purchase," said co-author Manoj Kumar Kanakasabapathy, a senior research assistant in the Shafiee laboratory. "Beyond human ovulation, there are applications here as well for animal breeding and even for dry eye disease, which can also produce fern-like patterns in samples from eye mucosa."

"One of the biggest problems with saliva-based tests, we realized, was that users find it difficult to interpret the fern patterns," said Prudhvi Thirumalaraju, another co-author of this study and a senior research assistant in Shafiee's laboratory. "We figured that advances in AI can be put to good use here, to help people get objective results on their smartphones."

The new system is constrained by some of the same limitations as traditional ovulation tests, and cannot detect ovulation in women with estrogen imbalance, cysts in the ovaries, and those who take fertility medications. Smoking or alcohol consumption may also interfere with accurate detection. The device will require additional testing in a larger population and approval by the Federal Drug Administration before it can be brought to market.

Potluri V, Kathiresan PS, Kandula H, Thirumalaraju P, Kanakasabapathy MK, Kota Sai Pavan S, Yarravarapu D, Soundararajan A, Baskar K, Gupta R, Gudipati N, C Petrozza J, Shafiee H.
An inexpensive smartphone-based device for point-of-care ovulation testing.
Lab Chip. 2018 Dec 18;19(1):59-67. doi: 10.1039/c8lc00792f.

Most Popular Now

Artificial Intelligence Detects a New Cl…

Many mutations in DNA that contribute to disease are not in actual genes but instead lie in the 99% of the genome once considered "junk." Even though scientists have recently...

Mobile Phone App Designed to Boost Physi…

Activity trackers and mobile phone apps are all the rage, but do they really help users increase and maintain physical activity? A new study has found that one mobile phone...

Application Period for an International …

The Master of Science (M.Sc.)in Medical Informatics (MMI) at European Campus Rottal-Inn (ECRI) in Pfarrkirchen - a branch of the Deggendorf University of Applied Sciences (THD - Technische Hochschule Deggendorf)...

Sectra to Provide Large Centralized Regi…

International medical imaging IT and cybersecurity company Sectra (STO: SECT B) has signed a five-year contract with North Tees and Hartlepool NHS Foundation Trust for the delivery of a regional...

Fussy, Hungry, or Even in Pain? Scientis…

Every parent knows the frustration of responding to a baby's cries, wondering if it is hungry, wet, tired, in need of a hug, or perhaps even in pain. A group...

IMI to Boost Patient Involvement in its …

The Innovative Medicines Initiative (IMI) is creating a 'pool' of patient experts to strengthen the role and voice of patients in IMI activities at both strategic and operational levels. IMI...

Merck Opens Application Phase for Next A…

Merck, a leading science and technology company, today announced that it has opened the next round of applications for startup companies to participate in the global Merck Accelerator program. Startups...

From One Brain Scan, more Information fo…

MIT researchers have devised a novel method to glean more information from images used to train machine-learning models, including those that can analyze medical scans to help diagnose and treat...

People with Mobility Issues Set to Benef…

The lives of thousands of people with mobility issues could be transformed thanks to ground-breaking research by scientists at the University of Bristol. The FREEHAB project will develop soft, wearable...

Regionalisation is No Silver Bullet for …

Opinion Article by Richard Turner, Executive Director, Change Healthcare In the late 1990s, radiology was a very different place. Still analogue, departments relied on light boxes, and professionals performedmore specific site-based...

XPOMET® Medicinale Welcomes Applications…

10 - 12 October 2019, Berlin, Germany. Ideas, concepts, collaboration - XPOMET Medicinale, the Future Health and Care Festival, is welcoming innovators to its event in October. Beyond the manifold offerings...